Castle Biosciences Inc
NASDAQ:CSTL

Watchlist Manager
Castle Biosciences Inc Logo
Castle Biosciences Inc
NASDAQ:CSTL
Watchlist
Price: 30.83 USD -3.05% Market Closed
Market Cap: 855.2m USD
Have any thoughts about
Castle Biosciences Inc?
Write Note

Castle Biosciences Inc
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Castle Biosciences Inc
Gross Profit Peer Comparison

Comparables:
DVA
DGX
CVS
CI
LH

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Castle Biosciences Inc
NASDAQ:CSTL
Gross Profit
$255.4m
CAGR 3-Years
52%
CAGR 5-Years
46%
CAGR 10-Years
N/A
DaVita Inc
NYSE:DVA
Gross Profit
$4.2B
CAGR 3-Years
5%
CAGR 5-Years
4%
CAGR 10-Years
1%
Quest Diagnostics Inc
NYSE:DGX
Gross Profit
$3.1B
CAGR 3-Years
-11%
CAGR 5-Years
3%
CAGR 10-Years
1%
CVS Health Corp
NYSE:CVS
Gross Profit
$52.4B
CAGR 3-Years
1%
CAGR 5-Years
4%
CAGR 10-Years
8%
Cigna Corp
NYSE:CI
Gross Profit
$26.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Laboratory Corporation of America Holdings
NYSE:LH
Gross Profit
$3.5B
CAGR 3-Years
-17%
CAGR 5-Years
2%
CAGR 10-Years
5%

See Also

What is Castle Biosciences Inc's Gross Profit?
Gross Profit
255.4m USD

Based on the financial report for Sep 30, 2024, Castle Biosciences Inc's Gross Profit amounts to 255.4m USD.

What is Castle Biosciences Inc's Gross Profit growth rate?
Gross Profit CAGR 5Y
46%

Over the last year, the Gross Profit growth was 70%. The average annual Gross Profit growth rates for Castle Biosciences Inc have been 52% over the past three years , 46% over the past five years .

Back to Top